Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China flag China · Delayed Price · Currency is CNY
9.10
-0.04 (-0.44%)
Sep 30, 2026, 3:04 PM CST

SHE:000590 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-48.32-50.52-125.4725.2518.1135.44
Depreciation & Amortization
30.7731.5429.2128.0424.3619.48
Other Amortization
3.252.260.891.10.971.2
Loss (Gain) From Sale of Assets
0.71-2.42-0-13.33-0.02-0.51
Asset Writedown & Restructuring Costs
24.9224.92118.715.590.672.02
Loss (Gain) From Sale of Investments
-1.5-0.780.5-2.79-2.77-3.33
Provision & Write-off of Bad Debts
-0.18-0.180.25---
Other Operating Activities
11.8611.929.354.992.07-1.86
Change in Accounts Receivable
-14.7738.52-4.29-45.832.92-26.83
Change in Inventory
2.4914.465.13-11.64-7.33-35.57
Change in Accounts Payable
-36.63-34.32-32.03-28.3215.5235.66
Change in Other Net Operating Assets
6.3-0.38-7.96-0.98-0.1
Operating Cash Flow
-24.1928.9617.39-29.3954.4725.2
Operating Cash Flow Growth
-66.54%--116.20%-51.06%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-42.06-48.81-32.1-22.04-18.68-25.88
Sale of Property, Plant & Equipment
2.450.130.010.22.670.71
Cash Acquisitions
-----214.52-
Divestitures
-0.41-----
Investment in Securities
-35--2550-94
Other Investing Activities
60.5460.30.540.992.993.18
Investing Cash Flow
-14.4911.62-31.554.15-177.54-115.98

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-6----
Long-Term Debt Issued
-48.6838.1120130.80.05
Total Debt Issued
15.1954.6838.1120130.80.05
Short-Term Debt Repaid
--6----
Long-Term Debt Repaid
--75.09-38.22-48.13-20.94-7.79
Lease Payments
-2.73-3.19-3.33-3.13-2.94-2.74
Total Debt Repaid
-85.63-81.09-38.22-48.13-20.94-7.79
Net Debt Issued (Repaid)
-70.45-26.41-0.11-28.13109.86-7.74
Issuance of Common Stock
--0.03---
Common Dividends Paid
-2.52-3.35-3.47-4.2-0.34-0.06
Other Financing Activities
-1.97-1.40.230.8222
Financing Cash Flow
-74.93-31.17-3.31-31.51111.52-5.81

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash Flow
-113.619.41-17.47-56.75-11.55-96.59

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-66.25-19.85-14.71-51.4335.79-0.68
Free Cash Flow Growth
------
Free Cash Flow Margin
-20.11%-5.88%-4.29%-12.71%10.21%-0.23%
Free Cash Flow Per Share
-0.28-0.08-0.06-0.210.15-0.00
Levered Free Cash Flow
20.7747.02-8.13-64.3421.79-23.75
Unlevered Free Cash Flow
22.2749.13-5.84-61.5522.52-23.45
Free Cash Flow After Leases
-68.98-23.04-18.04-54.5732.85-3.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
32.2146.3136.3652.0732.6832.78
Change in Working Capital
-45.7112.23-36.05-78.2411.08-27.24